(Answered) NR508 Week 3 Discussion

Week 3: Discussion

Mr. Russell is a 69-year-old male who presents to your clinic with complaints heart palpitations and light headedness on and off for the past month. He has a history of hypertension and is currently prescribed HCTZ.

Vital Signs: B/P 159/95, Irregular HR 78, Resp. 20, Weight 99 kilograms

Lower extremities with moderate 3+edema noted bilaterally, ABD + BS, Neuro AOX3,

Labs: NA 143mEq/L, CL 99 mmol/L BUN 18mg/dL, Hbg 15, TC 234 mg/dL, LDL 137 mg/dL, HDL 35 mg/dL, triglycerides 241mg/dL,

What are your treatment goals for Mr. Russell today?

What is your pharmacologic plan; please state your rationale for your plan?

What are five key patient education points based on your plan?

How would your plan change if your patient is African American?

How would your plan change if your patient complains of excessive heartburn and belching?


Based on Mr. Russell blood pressure B/P 159/95, his treatment goal is to get his BP to an average. This is for the purpose of reducing heart palpation and lightheadedness. The other goal is to educate him on lifestyle changes which include starting a regulate exercise program to manage his weight and eating a low fat as well as low-salt diet. The pharmacological plan is to use Amiloride combined with HCTZ. Roush and Sica (2016), explicate that Hydrochlorothiazide, which is a thiazide diuretic aids the body from taking in a lot of salt, which increases retention of fluids.  On the other hand, Amiloride, which is a potassium sparing-diuretic helps the body from absorbing a lot of salts and help prevent the potassium level from getting to a level that is considered as low….please click the icon below to purchase full solution at $5